This article has Open Peer Review reports available.
Eschar and neck lymphadenopathy caused by Francisella tularensis after a tick bite: a case report
© Edouard et al; licensee BioMed Central Ltd. 2011
Received: 25 May 2010
Accepted: 19 March 2011
Published: 19 March 2011
In 25 to 35% of cases, the aetiological agent of scalp eschar and neck lymphadenopathy after a tick bite remains undetermined. To date, Rickettsia slovaca, Rickettsia raoultii and more recently Bartonella henselae have been associated with this syndrome.
A four-year-old Caucasian boy was admitted to hospital with fever, vomiting and abdominal pain. On physical examination, an inflammatory and suppurating eschar was seen on the scalp, with multiple enlarged cervical lymph nodes on both sides. Although no tick was found in this scalp lesion, a diagnosis of tick-borne lymphadenopathy was suggested, and explored by serology testing and polymerase chain reaction of a biopsy from the eschar. Francisella tularensis DNA was found in the skin biopsy and the serology showed titres consistent with tularaemia.
This is, to the best of our knowledge, the first reported case of scalp eschar and neck lymphadenopathy after tick bite infection caused by F. tularensis.
In 1997, Raoult et al. described a new tick-borne disease caused by Rickettsia slovaca in a patient presenting with a single inoculation lesion of the scalp and cervical lymphadenopathy . In the same year, Lakos reported 27 cases of tick-transmitted infection with similar symptoms: an occipital scalp eschar and painful lymphadenopathy in the region of the tick bite. He named these infections tick-borne lymphadenopathy (TIBOLA) . In 2002, Raoult et al. suggested that R. slovaca may be a significant cause of TIBOLA . Later, Oteo et al. described a similar syndrome in Spain, which they named Dermacentor-borne necrosis erythemalymphadenopathy (DEBONEL) . To date, two aetiological agents, Rickettsia slovaca and more recently Rickettsia raoultii have been unquestionably associated with TIBOLA . Very recently, Angelakis et al. described the first cases of TIBOLA caused by Bartonella henselae and renamed this syndrome scalp eschar and neck lymphadenopathy after tick bite (SENLAT), to collectively describe this clinical entity. In some cases, the agent causing SENLAT has not been determined . These data indicate collectively that other causative agents of scalp eschars and neck adenopathy remain unknown. We report the first case of SENLAT caused by Francisella tularensis after tick bite.
Upon subsequent questioning, the child reported that he lived near a forest and was frequently bitten by ticks, approximately once or twice a week, particularly on the scalp. Although no tick was found in this scalp lesion, a diagnosis of TIBOLA was suggested and explored by serology and PCR of the eschar biopsy.
DNA was extracted from tissue samples (QIAamp Tissue Kit; Qiagen, Hilden, Germany). The eschar biopsy was screened by real-time PCR for F. tularensis using primers and probes targeting the yqaB gene with PCR carried out in a thermal cycler (LightCycler; Roche Diagnostics GmbH, Germany). The real-time PCR screen was positive for Francisella tularensis DNA in the skin biopsy, and negative for Rickettsia, Bartonella and Borrelia. spp., and for Coxiella burnetii. This result was confirmed by PCR of the 16S ribosomal RNA gene, which was found to be 99.8% identical to the GenBank sequence for F. tularensis (BK006741). The initial serology test, an indirect immunofluorescence assay, was negative. Three weeks later, further serology tests showed titres consistent with tularemia, including titres for IgG of 1: 400 and IgM of 1:100. To confirm the serological result, western blotting was performed on our patient's serum, which showed that F. tularensis was the causative agent. Concomitant indirect immunofluorescence assays for Rickettsia and Bartonella spp., C. burnetii and Borrelia burgdorferi were negative.
We treated our patient with doxycycline. The eschar and lymphadenopathy decreased after two weeks of treatment.
F. tularensis is the causative agent of tularemia, a bacterial zoonotic disease of the northern hemisphere. A wide range of arthropod vectors has been implicated in the transmission of F. tularensis between mammalian hosts. These vectors, particularly the Dermacentor, Amblyomma and Ixodes sp ticks. can also transmit the pathogen to humans [7, 8]. F. tularensis was first isolated from Dermacentor andersoni by Parker in 1924. Tick-borne transmission of tularemia is now known to occur throughout the northern hemisphere, with varying degrees of frequency in different geographic regions . In the USA, Sweden, Finland and Russia, arthropod bites are a common mode of transmission to humans, whereas in central Europe, arthropod-borne tularemia accounts for a much smaller number of human cases . Tularemia can take several forms in humans, depending on the route of entry of the bacterium into the body . After an infected tick bite, ulceroglandular tularaemia is the most common presentation of the disease . Ulceroglandular disease accounts for 60 to 80% of tularaemia cases; affected patients typically present with fever, skin eschar and tender regional lymphadenopathy .
In summary, we report the first case of SENLAT infection caused by F. tularensis. Neither scalp eschar nor neck lymphadenopathy due to F. tularensis have been described in the literature. Eschar is usually observed on the legs in cases of tick-borne tularemia .
SENLAT is a clinical entity most common in young children and women during colder seasons, and it is associated with R. slovaca, R. raoultii, B. henselae, B. burgdorferi and perhaps F. tularensis. However, the spectrum of causative agents of SENLAT was likely to be extended because the aetiological agent currently remains undetermined in 25 to 35% of c SENLAT cases .
Written informed consent was obtained from the parents of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Raoult D, Berbis P, Roux V, Xu W, Maurin M: A new tick-transmitted disease due to Rickettsia slovaca. Lancet. 1997, 350: 112-3. 10.1016/S0140-6736(05)61814-4.View ArticlePubMedGoogle Scholar
- Lakos A: TIBOLA - a new tick-borne disease. Orv Hetil. 1997, 138: 3229-32.PubMedGoogle Scholar
- Raoult D, Lakos A, Fenollar F, Beytout J, Brouqui P, Fournier PE: Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermatocentor ticks. Clin Infect Dis. 2002, 34: 1331-6. 10.1086/340100.View ArticlePubMedGoogle Scholar
- Oteo JA, Ibarra V, Blanco JR, Martinez de Artola V, Marquez FJ, Portillo A: Dermacentor-borne necrosis erythema and lymphadenopathy: clinical and epidemiological features of a new tick-borne disease. Clin Microbiol Infect. 2004, 10: 327-31. 10.1111/j.1198-743X.2004.00782.x.View ArticlePubMedGoogle Scholar
- Parola P, Rovery C, Rolain JM, Brouqui P, Davoust B, Raoult D: Rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerg Infect Dis. 2009, 15: 1105-8. 10.3201/eid1507.081449.View ArticlePubMedPubMed CentralGoogle Scholar
- Angelakis E, Pulcini C, Waton J, Imbert P, Socolovshi C, Edouard S: Scalp eschar and neck lymphadenopathy caused by Bartonella henselae after tick bite. Clin Infect Dis. 2010, 50: 549-51. 10.1086/650172.View ArticlePubMedGoogle Scholar
- Petersen JM, Mead PS, Schriefer ME: Francisella tularensis: an arthropod-borne pathogen. Vet Res. 2009, 40: 7-10.1051/vetres:2008045.View ArticlePubMedGoogle Scholar
- Oyston PC: Francisella tularensis: unravelling the secrets of an intracellular pathogen. J Med Microbiol. 2008, 57: 921-30. 10.1099/jmm.0.2008/000653-0.View ArticlePubMedGoogle Scholar
- Ohara Y, Sato T, Fujita H, Ueno T, Homma M: Clinical manifestations of tularemia in Japan--analysis of 1,355 cases observed between 1924 and 1987. Infection. 1991, 19: 14-7. 10.1007/BF01643750.View ArticlePubMedGoogle Scholar
- Ellis J, Oyston PC, Green M, Titball RW: Tularemia. Clin Microbiol Rev. 2002, 15: 631-46. 10.1128/CMR.15.4.631-646.2002.View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.